This rifle, caliber and suppressor combo make for a lightweight and exceptionally quiet game getter.

With Alibaba Group Holding Ltd. grabbing the spotlight of investor attention over China’s success in artificial intelligence, Tencent Holdings Ltd. is still waiting for its turn to shine.

But the recent decline in the stock market and uncertainty over how ... He’s postponing a trip to South Africa, and plans to meet with his financial advisor next week to decide whether to ...

Here are the two such oil stocks that could soar as Trump's energy plans take shape. This oil stock has big growth plans for the next five years ExxonMobil (NYSE: XOM) is the largest oil-producing ...

Oil stocks that have already charted out their growth plans could be the biggest winners under Trump. These oil stocks foresee huge growth in business, and Trump's energy plans should act as a ...

President Donald Trump on Thursday doubled down on his escalating tariff plans, even as his economic agenda continued to rattle investors and contribute to a weekslong stock market sell-off.

Looking back on design software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including PTC (NASDAQ:PTC) and its peers. The demand for rich, interactive 2D, 3D, VR and AR ...

Looking back on design software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including PTC (NASDAQ:PTC) and its peers. The demand for rich, interactive 2D ...

Gursky argues that current defense stock valuations assume U.S. defense ... is a premier aerospace firm engaged in the design, development, manufacturing, and support of a wide range of aircraft ...

Golden State Warriors forward Jonathan Kuminga plans to return and play on Thursday ... Coach Steve Kerr said Kuminga will come off the bench when he returns as he has settled on a starting ...

Soaring global bond yields are bearish for stocks. Plans announced Wednesday by Germany to amend its constitution to exempt defense and security outlays from limits on fiscal spending have sent ...

Timashev covers the Healthcare sector, focusing on stocks such as Axsome Therapeutics, Cytokinetics, and COMPASS Pathways. The analyst consensus on Design Therapeutics is currently a Hold rating.